UM-HMC-3A Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Head-Neck cancer cell lines |
| Organism |
Human |
| Donor History |
Hard palate mucoepidermoid carcinoma |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: DMEM:Ham's F12 (1:1) ,w: 3.1 g/L Glucose ,w: 2.5 mM L-Glutamine ,w: 15 mM HEPES ,w: 0.5 mM Sodium pyruvate ,w: 1.2 g/L NaHCO3 (Cytion article number 820400a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
UM-HMC-3A is a human mucoepidermoid carcinoma cell line established from the local recurrence of a salivary gland tumor in an adult patient, several years after surgical resection of the primary lesion. It is part of a matched pair of cell lines (UM-HMC-3A and UM-HMC-3B) derived from the same individual, representing distinct stages of disease progression, namely local recurrence and lymph node metastasis. UM-HMC-3A cells display a stable epithelial-like morphology in vitro, forming cobblestone-like monolayers and maintaining consistent growth characteristics over extended culture, with successful propagation reported beyond 100 passages. Short tandem repeat profiling confirms their origin from the patient tumor and excludes cross-contamination, supporting their reliability as a model system.
UM-HMC-3A demonstrates tumorigenic capacity in vivo, forming xenograft tumors when implanted into immunodeficient mice. These xenografts recapitulate key histopathological features of the original patient tumor, including the presence of both epidermoid-like and mucin-producing cell populations. Periodic Acid–Schiff (PAS) staining reveals mucopolysaccharide production comparable to human tumors, indicating preserved functional differentiation. Compared to its metastatic counterpart (UM-HMC-3B), UM-HMC-3A typically shows slower tumor formation and less consistent initial engraftment, reflecting biological differences associated with local recurrence versus metastatic progression. UM-HMC-3A provides a valuable, well-characterized model for investigating tumor recurrence, epithelial differentiation, and therapeutic responses in salivary gland mucoepidermoid carcinoma.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

